Status:
RECRUITING
Breath Analysis for the Detection of Invasive Fungal Infections
Lead Sponsor:
University of Zurich
Conditions:
Leukemia
Leukemia, Myeloid
Eligibility:
All Genders
18+ years
Brief Summary
Patients with leukemia and concomitant neutropenia are at high risk of developing invasive fungal infections (IFI) that are associated with high morbidity and mortality. As these patients typically ha...
Eligibility Criteria
Inclusion
- Diagnosis of acute leukemia
- Planned chemotherapy with a duration of hospitalisation of 2 weeks or longer
- Neutropenia (\<500/µl) present at inclusion or planned chemotherapy with expected neutropenia (\<500/µl) for more than 7 days
Exclusion
- Unable to follow instructions for breath analysis
- Anatomic abnormalities precluding the use of a mouthpiece for breath analysis
Key Trial Info
Start Date :
August 19 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2027
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06537726
Start Date
August 19 2024
End Date
October 31 2027
Last Update
April 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Zurich
Zurich, Canton of Zurich, Switzerland, 8091